Article · 4 May 2026
ArticlePublished 31 Aug 2024
2,3-Dimethylquinoxaline: A Natural Antifungal Drug with the Potential to Treat Eumycetoma, Oral Candidiasis and Other Fungal Infections
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
To evaluate the pharmacokinetics of 2,3-dimethylquinoxaline using web server (absorption, distribution, metabolism, and excretion), safety profile. Moreover, to assess the efficacy of 2,3-dimethylquinoxaline (a natural quinoxaline derivative) in vitro and in vivo. The absorption, distribution, metabolism, and excretion of 2,3-dimethylquinoxaline were predicted using the web servers Swiss absorption, distribution, metabolism, and excretion and ProTox-II, respectively. In vitro efficacy against Madurella mycetomatis and a wide range of other pathogenic fungi was determined by microdilution assay. In vivo activity was evaluated using a topical gel (1 %) in the Bagg Albino mice eumycetoma model and an oral candidiasis model. 2,3-dimethylquinoxaline showed favourable absorption, distribution, metabolism, and excretion drug-likeness features and a high safety profile. It inhibited Madurella mycetomatis at a minimum inhibitory concentration of 312 µg/ml and exhibited potent in vitro activity against a range of other fungi, including Cryptococcus neoformans (minimum inhibitory concentration=9 µg/ml) and Candida tropicalis is (minimum inhibitory concentration=1.125 µg/ml). In vivo, 2,3-dimethylquinoxaline gel was effective in treating both skin Madurella mycetomatis infection and oral candidiasis. 2,3-dimethylquinoxaline is a promising natural antifungal drug with the potential to treat eumycetoma and other fungal infections.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Abdelbagi Alfadil”
- BylineArticles whose byline prints “Karem Ibrahem”